Imlifidase, a New Option to Optimize the Management of Patients with Hemophilia A on Emicizumab.
Journal of Thrombosis and Haemostasis(2023)
关键词
hemophilia A,factor VIII,emicizumab,factor VIII inhibitors,IgG-degrading enzyme
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要